Wanbangde Pharmaceutical Holding Group (002082.SZ) equity distribution in 2023: 0.8 yuan per 10 shares.

Wanbangde Pharmaceutical Holding Group (002082.SZ) announced that their annual equity distribution plan for 2023 is as follows: based on the company's existing total share capital after deducting repurchased shares, every 10 shareholders will receive RMB 0.8 in cash (including taxes). The registration day for equity distribution is July 10, 2024, and the ex-rights and ex-dividend day is July 11, 2024.

Zhitong FinanceJul 4 05:47 ET

Wan Bond (002082.SZ): Huperzine A's indication for neonatal hypoxic ischemic encephalopathy was certified as an orphan drug by the US FDA

Wanbond (002082.SZ) issued an announcement. Wanbond Pharmaceutical Group Co., Ltd., a wholly-owned subsidiary of the company, announced in 202...

Zhitong FinanceMay 29 06:17 ET

Wan Bond (002082.SZ): Zhao Shouming, one of the actual controllers, completed a 1.188% increase in shares

Gelonghui, May 24 | Wan Bond (002082.SZ) announced that as of the announcement disclosure date, Mr. Zhao Shouming, one of the actual controllers, chairman and general manager of the company, had increased his holdings of the company's shares by 7,326,900 shares through centralized bidding transactions on the Shenzhen Stock Exchange, accounting for 1.1881% of the company's current total share capital. The amount of increase in holdings was 32.777.78 million yuan. The implementation of this share increase plan was completed.

Gelonghui FinanceMay 24 06:41 ET

Chairman Wan Bond (002082.SZ) increased his total share holdings by 1.19%

Wan Bond (002082.SZ) issued an announcement. As of May 8, 2024, the time for this holdings increase plan has passed...

Zhitong FinanceMay 9 06:33 ET

US FDA Gives Rare Pediatric Disease Drug Designation to Wanbangde Pharmaceutical's Huperzine A

The US Food and Drug Administration granted a rare pediatric disease drug designation to Huperzine A, a drug developed by Wanbangde Pharmaceutical Holding Group's (SHE:002082) unit, Wanbangde Pharmace

MT NewswiresMay 8 02:27 ET

Wanbangde Pharmaceutical Holding Group Co., Ltd.'s (SZSE:002082) Stock Is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Most readers would already be aware that Wanbangde Pharmaceutical Holding Group's (SZSE:002082) stock increased significantly by 15% over the past week. However, we decided to pay attention to the c

Simply Wall StApr 30 01:01 ET